SIRT1 and breast carcinoma: Altogether, it could be inferred that the marked elevation in circulating SIRT1 levels in breast cancer patients might be attributed to the significant presence of the high risk and high SIRT1-expressing rs3758391 and rs12778366 TT genotypes as well as the rs3740051 G allele carriers in breast cancer patients as compared to normal control subjects.